These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8957582

  • 1. Effect of phagocytosis of bacteria on the uptake of sparfloxacin by human neutrophils.
    García I, Pascual A, Ballesta S, Perea EJ.
    Chemotherapy; 1996; 42(6):465-7. PubMed ID: 8957582
    [Abstract] [Full Text] [Related]

  • 2. Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells.
    García I, Pascual A, Guzman MC, Perea EJ.
    Antimicrob Agents Chemother; 1992 May; 36(5):1053-6. PubMed ID: 1324636
    [Abstract] [Full Text] [Related]

  • 3. Bactericidal kinetics and postantibiotic effect of sparfloxacin against selected species of respiratory pathogens.
    Speciale A, Blandino G, Nicolosi VM, Siracusa V, Caccamo F.
    J Chemother; 1995 Dec; 7(6):530-4. PubMed ID: 8667038
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting the intracellular accumulation and activity of azithromycin.
    Pascual A, Conejo MC, García I, Perea EJ.
    J Antimicrob Chemother; 1995 Jan; 35(1):85-93. PubMed ID: 7768786
    [Abstract] [Full Text] [Related]

  • 5. Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils.
    García I, Pascual A, Salvador J, Conejo MC, Perea EJ.
    J Antimicrob Chemother; 1996 Nov; 38(5):859-63. PubMed ID: 8961056
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.
    Pascual A, García I, Ballesta S, Perea EJ.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):12-5. PubMed ID: 9869557
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
    Pruul H, McDonald PJ.
    J Antimicrob Chemother; 1990 Jan; 25(1):91-101. PubMed ID: 2108116
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
    Anderson R, Jooné GK.
    Chemotherapy; 1993 Jan; 39(6):424-31. PubMed ID: 8222871
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Negative impact of linezolid on human neutrophil functions in vitro.
    Grüger T, Schmidt T, Schnitzler N, Nidermajer S, Brandenburg K, Zündorf J.
    Chemotherapy; 2012 Jan; 58(3):206-11. PubMed ID: 22759803
    [Abstract] [Full Text] [Related]

  • 20. [Intracellular penetration of 5 quinolones into non-phagocytic cells].
    García I, Pascual A, Conejo MC, Perea EJ.
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):167-70. PubMed ID: 8695686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.